Literature DB >> 9207956

Rat prostate explants in serum-free organ culture: a comparison of two media and gas mixtures.

X K Nguyen-Le1, J Corcos, N Brière.   

Abstract

BACKGROUND: Urologists are looking for a way to easily discriminate between aggressive and very slow-growing prostate tumors. A sound way to appreciate such developing activities would be to identify an appropriate cell marker in prostate explants maintained in a defined culture system.
METHODS: Different biological parameters were compared in rat prostate explants cultured for 5 days in rich CMRL or basic Leibovitz's L-15 medium, unsupplemented with serum, under a mixture of either 95% air/5% CO2 or 50% N2/45% O2/5% CO2.
RESULTS: DNA synthesis was somewhat similar with the two-gas combination, but was higher in explants maintained in L-15 medium than in CMRL. Hence, L-15 medium and the 95% air/5% CO2 mixture were selected. Under these defined conditions for 5 days, cells were still able to synthesize DNA and proteins while preserving their morphological integrity and maintaining alkaline and acid phosphatase activities.
CONCLUSIONS: Since the present culture system works well in a controlled environment and under such minimal conditions, it appears to be a reliable and promising model that will provide basic data and allow the study of hormones and growth factors involved in prostatic tissue growth. It might eventually permit the identification of a cell marker.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207956     DOI: 10.1002/(sici)1097-0045(19970615)32:1<43::aid-pros6>3.0.co;2-d

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  1 in total

1.  Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour.

Authors:  Keng Wooi Ng; Marc Pearton; Sion Coulman; Alexander Anstey; Christopher Gateley; Anthony Morrissey; Christopher Allender; James Birchall
Journal:  Vaccine       Date:  2009-08-11       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.